The Chosun Ilbo on MSN

Obesity drug patents expire, generics drive market shift

The key component of Wegovy, which leads the global obesity treatment market, semaglutide, is losing patent protection in ...

China’s weight-loss drug makers take on global giants as Novo Nordisk patent expires

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss ...